Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COT


Primary Symbol: COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Bullboard Posts
Post by investor2003on Sep 21, 2006 8:59am
169 Views
Post# 11395656

Cott's revival

Cott's revivalOil, Aluminium, etc.... drop will sharply help Cott's bottom line. Aluminium is (like other base metals) going to fall probably 20%+ next year. We shall see oil at 20-40$ range IMO...closer to 40$ imo. Also, forget that nonsense about writeoffs. This company is allready turning around, just 2 months after Brent was named CEO. 3 upgrades just in the last month or so. With CEO, CFO buying close to 3 million $ worth of stock at about 15$ average, I see tremendous upside from here. Make no mistake. Brent is an excellent achiever. I have seen him in action at INBEV and wow!!! He is brilliant and really knows his company. He participated in TRIPLING INBEV stock price within 3-4 years! (https://www.inbev.com/investors/4__7__1__stockquote.cfm) Anyway, like Brent said, Cott's fundamentals are excellent. No doubt about that. The problem is simple: Mr. Sheppard. Looking at the Cott share price, he was nominated CEO in July 2003, within 8 months, the REALLLLLYYY stupid decisions of his, hamered the company like a rock. If you look at how bad he was, just go and read the Cott newsrelease back then, you will see within a few months that Mr. Sheppard (Cott ex-ceo) was nominated, he lost about 3-4 top management people. That tells it all. Anyway, with sales increasing of late, 1.8-2$ billion sales, with a market cap of 1.2 billion$, with positive earnings even if Mr. Sheppard really took all the bad decisions, well, can you only imagine the upside from here. I predict within 3 years, you will have a 60-70+ US Stock price. Time will tell, but from past history, whenever we had a recession, this stock balsted away. People tend to save more and go for less expensive brands (food, clothing, cars, etc..). Since market is 6 months minimum in anticipating results, I predict now is the time to get in since comes Q4, Brent will posts his earnings estimates, sales guidance, etc...for the next 2 years or so. And he will most likely never miss a single earning estimate judging from his past. Cost savings are HUGE. Also, don't forget, Brent wants to be number 1. THE best beverage company (non-alc) in the World. So, lot's of work ahead. cheers
Bullboard Posts